Page results
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
A research study has found that patients who get their chest X-ray results immediately are diagnosed in half the usual time.
-
Dr Tim Yates has a particular interest in the management of refractory headache disorders, particularly chronic migraine, the trigeminal autonomic cephalalgias, and facial pain syndromes.
-
UCLH is delighted that His Majesty King Charles III has accepted the patronages of University College Hospital and the Royal London Hospital for Integrated Medicine.
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
-
Dr Rather is a consultant physician & geriatrician with special interests in supporting patients with Parkinson’s, stroke and dementia. He also specialises in peri-operative care.
-
Jean Degala tells us how the right support, teamwork, effective communication, determination and dedication have helped her grow into the role.
-
The psychology team are running this workshop that uses a strengths based narrative approach to enable young people in years 10-13 to discuss the stresses surrounding exams and the additional challenges that having health problems add.
-
UCLH consultant Dr Arjuna Nagendran featured in the Royal Institution’s prestigious series on Boxing Day; this year presented by Professor Mike Woolridge on artificial intelligence (AI).
File results
-
FOI/2022/0283 - Enhanced disinfection methods to eliminate HAIs in theatres, clinical areas and wards
-
FOI/2022/0285 - Paediatric audiology
-
FOI/2022/0286 - Fat-shaming complaints
-
FOI/2022/0287 - Device related delays in delivery of medication/ enteral feeding
-
FOI/2022/0288 - Patient deaths awaiting discharge as inpatient
-
FOI/2022/0293 - Patients treated with Ponvory, Tysabri, Vumerity, Zeposia
-
FOI/2022/0294 - IT systems validation document management system
-
FOI/2022/0295 - Procurement Organisation Structure chart
-
FOI/2022/0300 - EPRR Coordination of emergency/disaster management activities
-
FOI/2022/0302 - Treatment with conditions for rheumatology/ dermatology